Ziang Xie

3.1k total citations · 1 hit paper
45 papers, 2.2k citations indexed

About

Ziang Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ziang Xie has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 16 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Ziang Xie's work include Bone Metabolism and Diseases (17 papers), Bone health and treatments (13 papers) and MicroRNA in disease regulation (6 papers). Ziang Xie is often cited by papers focused on Bone Metabolism and Diseases (17 papers), Bone health and treatments (13 papers) and MicroRNA in disease regulation (6 papers). Ziang Xie collaborates with scholars based in China, United States and Mexico. Ziang Xie's co-authors include Shunwu Fan, Yan Ma, Shuying Shen, Jiying Wang, Gangliang Wang, Yizheng Wu, Zhiwei Jie, Kangmao Huang, Junxin Chen and Peihua Shi and has published in prestigious journals such as Nature Communications, The FASEB Journal and Free Radical Biology and Medicine.

In The Last Decade

Ziang Xie

43 papers receiving 2.2k citations

Hit Papers

Desktop-stereolithography... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Desktop-stereolithography 3D printing of a radially oriented extracellular matrix/mesenchymal stem cell exosome bioink for osteochondral defect regeneration
    2019 374 citations Lin Zheng, Ziang Xie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziang Xie China 23 1.6k 837 463 273 256 45 2.2k
Ziji Zhang China 29 1.6k 1.0× 1.1k 1.3× 1.2k 2.7× 106 0.4× 182 0.7× 84 2.8k
Shunwu Fan China 21 827 0.5× 409 0.5× 402 0.9× 216 0.8× 111 0.4× 62 1.8k
Xianzhe Liu China 27 1.1k 0.7× 784 0.9× 244 0.5× 153 0.6× 378 1.5× 64 2.2k
Baoan Ma China 30 1.3k 0.8× 1.1k 1.3× 328 0.7× 128 0.5× 407 1.6× 83 2.4k
Merissa Olmer United States 24 749 0.5× 350 0.4× 702 1.5× 158 0.6× 138 0.5× 42 1.7k
Bruno Fuchs Switzerland 31 876 0.6× 478 0.6× 182 0.4× 303 1.1× 442 1.7× 64 2.2k
Xiaolong Xu China 23 1.1k 0.7× 514 0.6× 102 0.2× 209 0.8× 286 1.1× 83 1.9k
Chun Zeng China 23 792 0.5× 291 0.3× 867 1.9× 91 0.3× 239 0.9× 73 1.9k
Hiroko Sudo Japan 16 1.5k 1.0× 424 0.5× 352 0.8× 109 0.4× 466 1.8× 32 2.7k
Win‐Ping Deng Taiwan 28 687 0.4× 212 0.3× 365 0.8× 264 1.0× 302 1.2× 62 2.2k

Countries citing papers authored by Ziang Xie

Since Specialization
Citations

This map shows the geographic impact of Ziang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziang Xie more than expected).

Fields of papers citing papers by Ziang Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziang Xie. The network helps show where Ziang Xie may publish in the future.

Co-authorship network of co-authors of Ziang Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Ziang Xie. A scholar is included among the top collaborators of Ziang Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziang Xie. Ziang Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Qingliang, Shiyu Wang, Xue Hong, et al.. (2025). Targeting Msx2 as a brake in the fusion fate of osteoclasts and an anabolic therapy in pre-clinical models of osteoporosis. Nature Communications. 16(1). 7228–7228.
2.
Wang, Haoming, Lijun Li, Hongwei Xie, et al.. (2025). FTO SUMOylation regulates the differentiation of bone marrow mesenchymal stromal cells in inflammatory bowel disease-induced bone loss. Cell Reports. 44(7). 115953–115953.
3.
Shen, Yang, Haoming Wang, Hongwei Xie, et al.. (2024). l-arginine promotes angio-osteogenesis to enhance oxidative stress-inhibited bone formation by ameliorating mitophagy. Journal of Orthopaedic Translation. 46. 53–64. 14 indexed citations
4.
Xie, Ziang, Yizheng Wu, Yang Shen, et al.. (2023). USP7 Inhibits Osteoclastogenesis via Dual Effects of Attenuating TRAF6/TAK1 Axis and Stimulating STING Signaling. Aging and Disease. 14(6). 2267–2267. 14 indexed citations
5.
Li, Liangping, Xiaoying Chen, Xiang Li, et al.. (2021). Oxidative Stress-Induced Hypermethylation of KLF5 Promoter Mediated by DNMT3B Impairs Osteogenesis by Diminishing the Interaction with β-Catenin. Antioxidants and Redox Signaling. 35(1). 1–20. 26 indexed citations
6.
Teng, Yao, Yute Yang, Ziang Xie, et al.. (2021). Circ0083429 Regulates Osteoarthritis Progression via the Mir-346/SMAD3 Axis. Frontiers in Cell and Developmental Biology. 8. 579945–579945. 13 indexed citations
7.
8.
Zhang, Xuyang, Ziang Xie, Yilei Chen, et al.. (2020). Homocysteine induces oxidative stress and ferroptosis of nucleus pulposus via enhancing methylation of GPX4. Free Radical Biology and Medicine. 160. 552–565. 151 indexed citations
9.
Mei, Zhendong, Xin Dong, Yu Qian, et al.. (2020). Association between the metabolome and bone mineral density in a Chinese population. EBioMedicine. 62. 103111–103111. 39 indexed citations
10.
Gao, Hongliang, Jiayong Dai, Yu Gu, et al.. (2020). Small molecule inhibitor of TAK1 ameliorates rat cartilaginous endplate degeneration induced by oxidative stress in vitro and in vivo. Free Radical Biology and Medicine. 148. 140–150. 9 indexed citations
11.
Zhao, Xiangde, Lei Ning, Ziang Xie, et al.. (2019). The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen-Dependent Bone Loss in Mice. Journal of Bone and Mineral Research. 34(5). 911–922. 26 indexed citations
12.
13.
Huang, Bao, Jiasheng Wang, Xuyang Zhang, et al.. (2019). Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss via Suppressing Osteoclastogenesis in Mice. Frontiers in Pharmacology. 10. 900–900. 5 indexed citations
14.
Zhang, Boya, Xin Pan, Hai Huang, et al.. (2019). Octyl itaconate inhibits osteoclastogenesis by suppressing Hrd1 and activating Nrf2 signaling. The FASEB Journal. 33(11). 12929–12940. 56 indexed citations
15.
Li, Xiang, Lei Ning, Jianjun Ma, et al.. (2019). The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice. Cell Communication and Signaling. 17(1). 136–136. 22 indexed citations
16.
Shen, Shuying, Yizheng Wu, Junxin Chen, et al.. (2019). CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene. Annals of the Rheumatic Diseases. 78(6). 826–836. 225 indexed citations
17.
Wang, Qiang, Jian Mo, Chenchen Zhao, et al.. (2018). Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells. Cell Death and Disease. 9(3). 376–376. 32 indexed citations
18.
Tang, Pan, Jiaming Gu, Ziang Xie, et al.. (2018). Honokiol alleviates the degeneration of intervertebral disc via suppressing the activation of TXNIP-NLRP3 inflammasome signal pathway. Free Radical Biology and Medicine. 120. 368–379. 119 indexed citations
19.
Jie, Zhiwei, Ziang Xie, Xiangde Zhao, et al.. (2018). Glabridin inhibits osteosarcoma migration and invasion via blocking the p38‐ and JNK‐mediated CREB–AP1 complexes formation. Journal of Cellular Physiology. 234(4). 4167–4178. 19 indexed citations
20.
Jie, Zhiwei, Ziang Xie, Wenbin Xu, et al.. (2018). SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(1). 115–125. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziji Zhang Breakdown of academic impact, for papers by Shunwu Fan Breakdown of academic impact, for papers by Xianzhe Liu Breakdown of academic impact, for papers by Baoan Ma Breakdown of academic impact, for papers by Merissa Olmer Breakdown of academic impact, for papers by Bruno Fuchs Breakdown of academic impact, for papers by Xiaolong Xu Breakdown of academic impact, for papers by Chun Zeng Breakdown of academic impact, for papers by Hiroko Sudo Breakdown of academic impact, for papers by Win‐Ping Deng
Rankless by CCL
2026